BMO lifts Fiserv stock target to $260, maintains outperform
BMO Capital Markets updated its outlook on Fiserv (NYSE:FI) shares, raising the price target to $260 from the previous $233, while reiterating an Outperform rating. The adjustment follows Fiserv's ...
TD Cowen Sticks to Its Buy Rating for Symbotic (SYM)
TD Cowen analyst Joseph C Giordano maintained a Buy rating on Symbotic (SYM – Research Report) today and set a price target of $45.00. The ...
Cigna downgraded to Market Perform from Outperform at Bernstein
Bernstein downgraded Cigna (CI) to Market Perform from Outperform with a $323 price target The firm cites underperformance in the company’s ...
Thursday’s analyst upgrades and downgrades
Seeing “growth on hiatus,” Mr. Bir reduced his own forecast for 2025 and 2026 “with revisions mainly for longer lease-up ...
RBC cuts Regeneron stock price target to $1,045, keeps Outperform
RBC Capital Markets adjusted its price target for Regeneron Pharmaceuticals (NASDAQ:REGN), reducing it to $1,045 from the previous target of $1,059. Despite the decrease, the firm maintained its ...